转移性肺结节的临床试验
总计18024个结果
-
Mayo ClinicNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)完全的
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City完全的
-
Copernicus Memorial HospitalMedical Research Agency, Poland招聘中
-
The First Affiliated Hospital of Guangzhou Medical...未知
-
Institut Cancerologie de l'Ouest完全的
-
UNICANCERNational Cancer Institute, France招聘中
-
Capital Medical UniversityDuke University撤销
-
Ohio State University Comprehensive Cancer Center招聘中
-
Jonsson Comprehensive Cancer CenterMedivation, Inc.; BioMarin Pharmaceutical; Translational Research in Oncology完全的
-
Daiichi SankyoAstraZeneca招聘中
-
Memorial Sloan Kettering Cancer CenterRepare Therapeutics招聘中
-
Imperial College LondonCuresponse Ltd.尚未招聘
-
Meryx, Inc.主动,不招人
-
Samsung Medical Center完全的
-
P.O. WitteveenErasmus Medical Center; The Netherlands Cancer Institute终止
-
Virginia Commonwealth University终止
-
NRG OncologyNational Cancer Institute (NCI)主动,不招人解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 骨转移性恶性肿瘤 | 淋巴结转移性恶性肿瘤 | 肝脏转移性恶性肿瘤 | 转移性乳腺癌 | 肺部转移性恶性肿瘤 | 脊柱转移性恶性肿瘤 | IV 期乳腺癌美国癌症联合委员会 (AJCC) v8美国, 加拿大, 沙特阿拉伯, 大韩民国
-
National Cancer Institute (NCI)完全的
-
AstraZeneca完全的具有腺癌和非腺癌组织学的 aNSCLC 患者(局部晚期和/或转移性疾病)的 EGFR 突变状态。意大利, 西班牙, 英国, 瑞典, 日本, 荷兰, 德国, 法国
-
Minerva A Romero Arenas完全的
-
The Belgian Society of Medical OncologyRoche Pharma AG; Foundation Medicine; Sciensano招聘中
-
Oslo University HospitalThe Research Council of Norway完全的